Decline in verbal memory during preclinical Alzheimer's disease: Examination of the effect of APOE genotype

Journal of the International Neuropsychological Society

Volumn 8, Issue 7, 2002, Pages 943-955

  Lange, Kelly L ^a   Bondi, Mark W ^a   Salmon, David P ^a   Galasko, Douglas ^a   Delis, Dean C ^a   Thomas, Ronald G ^a   Thal, Leon J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alzheimer's disease; Apolipoprotein E; Episodic memory; Neuropsychology; Preclinical Alzheimer's disease

Indexed keywords

APOLIPOPROTEIN E;

AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DEMENTIA; DEPTH PERCEPTION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GENOTYPE; HUMAN; LEARNING TEST; MAJOR CLINICAL STUDY; MALE; NEUROFIBRILLARY TANGLE; PRIORITY JOURNAL; RATING SCALE; SENSITIVITY ANALYSIS; VERBAL MEMORY;

EID: 0036849434     PISSN: 13556177     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1355617702870096     Document Type: Article

References (68)

1. Albert, M.S., Moss, M.B., Tanzi, R., & Jones, K. (2001). Preclinical prediction of AD using neuropsychological tests. Journal of the International Neuropsychological Society, 7, 631-639.
2. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.
3. Bäckman, L. & Small, B.J. (1998). Influences of cognitive support on episodic remembering: Tracing the loss from normal aging to Alzheimer's disease. Psychology and Aging, 13, 267-276.
4. Bäckman, L., Small, B.J., & Fratiglioni, L. (2001). Stability of the preclinical episodic memory deficit in Alzheimer's disease. Brain, 124, 96-102.
5. Basun, H., Grut, M., Winblad, B., & Lannfelt, L. (1995). Apolipoprotein ∈4 allele and disease progression in patients with late-onset Alzheimer's disease. Neuroscience Letters, 183, 32-34.
6. Becker, J.T., Mintum, M.A., Aleva, K., Wiseman, M.B., Nichols, T., & DeKosky, S.T. (1996). Compensatory reallocation of brain resources supporting verbal episodic memory in Alzheimer's disease. Neurology, 46, 692-700.
7. Blessed, G., Tomlinson, B.E., & Roth, M. (1968). The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. British Journal of Psychiatry, 114, 797-811.
8. Bondi, M.W., Monsch, A.U., Galasko, D., Butters, N., Salmon, D.P., & Delis, D.C. (1994). Preclinical cognitive markers of dementia of the Alzheimer type. Neuropsychology, 8, 374-384.
9. Bondi, M.W., Salmon, D.P., Galasko, D., Thomas, R.G., & Thal, L.J. (1999). Neuropsychological function and apolipoprotein E genotype in the preclinical detection of Alzheimer's disease. Psychology and Aging, 14, 295-303.
10. Bookheimer, S.Y., Strojwas, M.H., Cohen, M.S., Saunders, A.M., Pericak-Vance, M.A., Mazziotta, J.C., & Small, G.W. (2000). Patterns of brain activation in people at risk for Alzheimer's disease. New England Journal of Medicine, 343, 450-456.
11. Braak, H. & Braak, E. (1991). Neuropathological staging of Alzheimer-related changes. Acta Neuropathologica, 82, 239-259.
12. Braak, H., Braak, E., Bohl, J., & Bratzke, H. (1998). Evolution of Alzheimer's disease related cortical lesions. Journal of Neural Transmission 54, (Suppl.), 97-106.
13. Burggren, A.C., Small, G.W., Sabb, F.W., & Bookheimer, S.Y. (2002). Specificity of brain activation patterns in people at genetic risk for Alzheimer's disease. American Journal of Geriatric Psychiatry, 10, 44-51.
14. Chen, P., Ratcliff, G., Belle, S.H., Cauley, J.A., DeKosky, S.T., & Ganguli, M. (2001). Patterns of cognitive decline in presymptomatic Alzheimer disease: A prospective community study. Archives of General Psychiatry, 58, 853-858.
15. Collie, A. & Maruff, P. (2000). The neuropsychology of preclinical Alzheimer's disease and mild cognitive impairment. Neuroscience and Biobehavioral Reviews, 24, 365-374.
16. Corder, E.H., Saunders, A.M., Strittmatter, W.J., Schmechel, D.E., Gaskell, P.C., Rimmler, J.B., Locke, P.A., Conneally, P.M., Schmader, K.E., Tanzi, R.E., Gusella, J.F., Small, G.W., Roses, A.D., Pericak-Vance, M.A., & Haines, J.L. (1995). Apolipoprotein E, survival in Alzheimer's disease patients, and the competing risks of death and Alzheimer's disease. Neurology, 45, 1323-1328.
17. Corder, E.H., Saunders, A.M., Strittmatter, W.J., Schmechel, D.E., Gaskell, P.C., Small, G.W., Roses, A.D., Haines, J.L., & Pericak-Vance, M.A. (1993). Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science, 261, 921-923.
18. Craft, S., Teri, L., Edland, S.D., Kukull, W.A., Schellenberg, G., McCormick, W.C., Bowen, J.D., & Larsen, E.B. (1998). Accelerated decline in apolipoprotein E-ε4 homozygotes with Alzheimer's disease. Neurology, 51, 149-153.
19. Dal Forno, G., Rasmusson, X., Brandt, J., Carson, K.A., Brookmeyer, R., Troncoso, J., & Kawas, C.H. (1996). Apolipoprotein E genotype and rate of decline in probable Alzheimer's disease. Archives of Neurology, 53, 345-350.
20. DeKosky, S.T., Ferrell, R., Kamboh, M.I., & Becker, J.T. (1995). Natural history of definite AD as a function of APOE genotypes. Neurology, 5 (Suppl. 4), A373.
21. DeKosky, S.T., Ikonomovic, M.D., Styren, S.D., Beckett, L., Wisniewski, S., Bennett, D.A., Cochran, E.J., Kordower, J.H., & Mufson, E.J. (2002). Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment. Annals of Neurology, 51, 145-155.
22. Delis, D.C., Kramer, J.H., Kaplan, E., & Ober, B.A. (1987). California Verbal Learning Test. New York: The Psychological Corporation.
23. Delis, D.C., Massman, P.J., Butters, N., Salmon, D.P., Kramer, J.H., & Cermak, L. (1991). Profiles of demented and amnesic patients on the CVLT: Implications for the assessment of memory disorders. Psychological Assessment, 3, 19-26.
24. Desgranges, B., Baron, J.C., & Eustache, F. (1998). The functional neuroanatomy of episodic memory: The role of the frontal lobes, the hippocampal formation, and other areas. Neuroimage, 8, 198-213.
25. Dik, M.G., Jonker, C., Bouter, L.M., Geerlings, M.I., van Kamp, G.J., & Deeg, D.J.H. (2000). APOE-ε4 is associated with memory decline in cognitively impaired elderly. Neurology, 54, 1492-1497.
26. Folstein, M.F., Folstein, S., & McHugh, P.R. (1975). Mini-Mental State: A practical method of grading the cognitive state of patients for the clinician. Journal of Psychiatry Research, 12, 189-198.
27. Frisoni, G.B., Govoni, S., Geroldi, C., Bianchetti, A., Calabresi, L., Franceschini, G., & Trabucchi, M. (1995). Gene dose of the ∈4 allele of apolipoprotein E and disease progression in sporadic late-onset Alzheimer's disease. Annals of Neurology, 37, 596-604.
28. Fuld, P.A., Masur, D.M., Blau, A.D., Crystal, H., & Aronson, M.K. (1990). Object-memory evaluation for prospective detection of dementia in normal functioning elderly: Predictive and normative data. Journal of Clinical and Experimental Neuropsychology, 12, 520-528.
29. Galasko, D., Kwo-on-Yuen, P.F., Klauber, M.R., & Thai, L.J. (1990). Neurological findings in Alzheimer's disease and normal aging. Archives of Neurology, 47, 625-627.
30. Geroldi, C., Laasko, M.P., DeCarli, C., Beltramello, A., Bianchetti, A., Soininen, H., Trabucchi, M., & Frisoni, G.B. (2000). Apolipoprotein E genotype and hippocampal asymmetry in Alzheimer's disease: A volumetric MRI study. Journal of Neurology, Neurosurgery, and Psychiatry, 68, 93-96.
31. Gomez-Isla, T., West, H.L., Rebeck, G.W., Harr, S.D., Growdon, J.H., Locascio, J.J., Perls, T.T., Lipsitz, L.A., & Hyman, B.T. (1996). Clinical and pathological correlates of apolipoprotein E ε4 in Alzheimer's disease. Annals of Neurology, 39, 62-70.
32. Grober, E. & Kawas, C. (1997). Learning and retention in preclinical and early Alzheimer's disease. Psychology and Aging, 12, 183-188.
33. Growdon, J.H., Locascio, J.J., Corkin, S., Gomez-Isla, T., & Hyman, B.T. (1996). Apolipoprotein E genotype does not influence rates of cognitive decline in Alzheimer's disease. Neurology, 47, 444-448.
34. Howieson, D.B., Dame, A., Camicioli, R., Sexton, G., Payami, H., & Kaye, J.A. (1997). Cognitive markers preceding Alzheimer's dementia in the healthy oldest old. Journal of the American Geriatrics Society, 45, 584-589.
35. Hyman, B.T., Gomez-Isla, T., Briggs, M., Chung, H., Nichols, S., Kohout, F., & Wallace, R. (1996). Apolipoprotein E and cognitive change in an elderly population. Annals of Neurology, 40, 55-66.
36. Hyman, B.T., Gomez-Isla, T., Rebeck, G.W., Briggs, M., Chung, H., West, H.L., Greenberg, S., Mui, S., Nichols, S., Wallace, R., & Growdon, J.H. (1996). Epidemiological, clinical, and neuropathological study of apolipoprotein E genotype in Alzheimer's disease. Annals of the New York Academy of Sciences, 802, 1-5.
37. Hyman, B.T., Van Hoesen, G.W., Damasio, A., & Barnes, C.L. (1984). Alzheimer's disease: Cell-specific pathology isolates the hippocampal formation. Science, 225, 1168-1170.
38. Jacobs, D.M., Sano, M., Dooneief, G., Marder, K., Bell, K.L., & Stern, Y. (1995). Neuropsychological detection and characterization of preclinical Alzheimer's disease. Neurology, 45, 957-962.
39. Jack, C.R., Petersen, R.C., O'Brien, P.C., & Tangalos, E.G. (1992). MR-based hippocampal volumetry in the diagnosis of Alzheimer's disease. Neurology, 42, 183-188.
40. Killiany, R.J., Moss, M.B., Albert, M.S., Sandor, T., Tieman, J., & Joleaz, F. (1993). Temporal lobe regions on magnetic resonance imaging identify patients with early Alzheimer's disease. Archives of Neurology, 50, 949-954.
41. Katzman, R. (1986). Alzheimer's disease. New England Journal of Medicine, 314, 964-973.
42. Kurz, A., Egensperger, R., Haupt, M., Lautenschlager, N., Romero, B., Graeber, M.B., & Muller, U. (1996). Apolipoprotein E ε4 allele, cognitive decline, and deterioration of everyday performance in Alzheimer's disease. Neurology, 47, 440-443.
43. Linn, R.T., Wolf, P.A., Bachman, D.L., Knoefel, J.E., Cobb, J.L., Belanger, A.J., Kaplan, E.F., & D'Agostino, R.B. (1995). The 'preclinical phase' of probable Alzheimer's disease. Archives of Neurology, 52, 485-490.
44. Mattis, S. (1988). Dementia Rating Scale: Professional manual. Odessa, FL: Psychological Assessment Resources.
45. Mayeux, R., Small, S.A., Tang, M.-X., Tycko, B., & Stern, Y. (2001). Memory performance in healthy elderly without Alzheimer's disease: Effects of time and apolipoprotein-E. Neurobiology of Aging, 22, 683-689.
46. McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E.M. (1984). Clinical diagnosis of Alzheimer's disease: Report of the NINCSD-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology, 34, 939-944.
47. Nagy, Z., Hindley, N.J., Braak, H., Braak, E., Yilmazer-Hanke, D.M., Schultz, C., Barnetson, L., King, E.M., Jobst, K.A., & Smith, A.D. (1999). The progression of Alzheimer's disease from limbic to the neocortex: Clinical, radiological and pathological relationships. Dementia: Geriatric and Cognitive Disorders, 10, 115-120.
48. Normann, J., Brookes, A.J., Yates, C., & St. Clair, D. (1995). Apolipoprotein E genotype and its effect on duration and severity of early and late onset Alzheimer's disease. British Journal of Psychiatry, 167, 533-536.
49. Ohm, T.G., Kirca, M., Bohl, J., Scharnagl, H., Grob, W., & Marz, W. (1995). Apolipoprotein E polymorphism influences not only cerebral senile plaque load but also Alzheimer-type neurofibrillary tangle formation. Neuroscience, 66, 583-587.
50. Petersen, R.C., Doody, R., Kurz, A., Mohs, R.C., Morris, J.C., Rabins, P.V., Ritchie, K., Rossor, M., That, L., & Winblad, B. (2001). Current concepts in mild cognitive impairment. Archives of Neurology, 58, 1985-1992.
51. Petersen, R.C., Smith, G.E., Ivnik, R.I., Tangalos, E.G., Schaid, D.J., Thibodeau, S.N., Kokmen, E., Waring, S.C., & Kurland, L.T. (1995). Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals. Journal of the American Medical Association, 273, 1274-1278.
52. Pfeffer, R., Kurosaki, T.T., Harrah, C.H., Chance, J.M., & Filos, S. (1982). Measurement of functional activities in older adults in the community. Journal of Gerontology, 37, 323-329.
53. Rubin, E.H., Storandt, M., Miller, J.P., Kinscherf, D.A., Grant, E.A., Morris, J.C., & Berg, L. (1998). A prospective study of cognitive function and onset of dementia in cognitively healthy elders. Archives of Neurology, 55, 395-401.
54. Salmon, D.P. & Bondi, M.W. (1999). Neuropsychology of Alzheimer disease. In R.D. Terry, R. Katzman, K.L. Bick, & S.S. Sisodia (Eds.), Alzheimer disease (2nd ed., pp. 39-56). Philadelphia: Lippincott Williams & Wilkins.
55. Salmon, D.P. & Butters, N.M. (1992). Neuropsychologic assessment of dementia in the elderly. In R. Katzman & J.W. Rowe (Eds.), Principles of geriatric neurology (pp. 144-163). New York: F.A. Davis.
56. Saunders, A.M., Strittmatter, W.J., Schmechel, D., St. George-Hyslop, P.H., Pericak-Vance, M.A., Joo, S.H., Rosi, B.L., Gusella, J.F., Crapper-MacLachlan, D.R., Alberts, M.J., Hulette, C., Crain, B., Goldgaber, D., & Roses, A.D. (1993). Association of apolipoprotein E allele e4 with late-onset familial and sporadic Alzheimer's disease. Neurology, 43, 1467-1472.
57. Schmechel, D.E., Saunders, A.M., Strittmatter, W.J., Crain, B.J., Hulette, C.M., Joo, S.H., Pericak-Vance, M.A., Goldgaber, D., & Roses, A.D. (1993). Increased amyloid β-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proceedings of the National Academy of Sciences (USA), 90, 9649-9653.
58. Small, B.J., Basun, H., & Bäckman, L. (1998). Three-year changes in cognitive performance as a function of apolipoprotein E genotype: Evidence from very old adults without dementia. Psychology and Aging, 13, 80-87.
59. Small, B.J., Fratiglioni, L., Viitanen, M., Winblad, B., & Bäckman, L. (2000). The course of cognitive impairment in preclinical Alzheimer disease: Three- and 6-year follow-up of a population-based sample. Archives of Neurology, 57, 839-844.
60. Smith, G.E., Bohac, D.L., Waring, S.C., Kokmen, E., Tangalos, E.G., Ivnik, R.I., & Petersen, R.C. (1998). Apolipoprotein E genotype influences cognitive 'phenotype' in patients with Alzheimer's disease but not in healthy control subjects. Neurology, 50, 355-362.
61. Soininen, H., Partanen, K., Pitkanen, A., Hallikainen, M., Hanninen, T., Helisalmi, S., Mannermaa, A., Ryynanen, M., Koivisto, K., & Riekkinen, P., Sr. (1995). Decreased hippocampal volume asymmetry on MRIs in nondemented elderly subjects carrying the apolipoprotein E epsilon 4 allele. Neurology, 45, 391-392.
62. Soininen, H.S. & Riekkinen, P.J. (1996). Apolipoprotein E, memory and Alzheimer's disease. Trends in Neurosciences, 19, 224-228.
63. Strittmatter, W.J., Saunders, A.M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G.S., & Roses, A.D. (1993). Apolipoprotein E: High-avidity binding to, β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proceedings of the National Academy of Sciences (USA), 90, 1977-1981.
64. Strittmatter, W.J., Weisgraber, K.H., Goedert, M., Saunders, A.M., Huang, D., Corder, E.H., Dong, L.-M., Jakes, R., Alberts, M.J., Gilbert, J.R., Han, S.-H., Hulette, C., Einstein, G., Schmechel, D.E., Pericak-Vance, M.A., & Roses, A.D. (1994). Hypothesis: Microtubule instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotein E genotype. Experimental Neurology, 125, 163-171.
65. Terry, R.D., Masliah, E., Salmon, D.P., Butters, N., DeTeresa, R., Hill, R., Hansen, L.A., & Katzman, R. (1991). Physical basis of cognitive alterations in Alzheimer's disease: Synapse loss is the major correlate of cognitive impairment. Annals of Neurology, 30, 572-580.
66. Tierney, M.C., Szalai, J.P., Snow, W.G., Fisher, R.H., Nores, A., Nadon, G., Dunn, E., & St George-Hyslop, P.H. (1996). Prediction of probable Alzheimer's disease in memory-impaired patients: A prospective longitudinal study. Neurology, 46, 661-665.
67. Wechsler, D. (1987). Wechsler Memory Scale-Revised. New York: The Psychological Corporation.
68. Zelinski, E.M. & Burnight, K.P. (1997). Sixteen-year longitudinal and time lag changes in memory and cognition in older adults. Psychology and Aging, 12, 503-513.